PerkinElmer
check quantity

1/2 Area ViewPlate-96 well Microplates, PS, TC, White, Sterile, Case of 40

96-well white with clear bottom 1/2 area microplate with tissue culture treatment (TC-treated) for cell-based assays. Half-area plates utilize the same well spacing as a regular 96-well plate, but contain wells with half the diameter of a typical 96-well plate. This enables miniaturization to lower assay volumes while retaining ease-of-pipetting.

Part Number
Unit Size
List Price
Your Price
Quantity
6005760
Case of 40
442.00 USD
 
more
6005768
Case of 160
1724.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

PerkinElmer's ½ AreaPlate offers same well depth at half the size to help you miniaturize your assay, designed to utilize cost reduction advantages without going to a 384-well format.

Leveraging years of assay and instrument experience in plate detection, PerkinElmer designs better microplates for better performance that guarantees better results for all PerkinElmer applications.

Specifications

Automation Compatible Yes
Coating Treatment TC-treated, Sterile
Color White/Clear Bottom
Detection Method Luminescence, Time-Resolved Fluorescence (TRF & TR-FRET), Radiometric
Format Microplates
Material Polystyrene
Product Brand Name ½ AreaPlate,ViewPlate
Quantity in a Package Amount 40.0 Units
Shipping Condition Ambient
Sterile Yes
Unit Size Case of 40
Wells Number 96 well plate
Well Shape 1/2 Area
Resources, Events & More
  • All

Application Note

Measuring PD-L1 Expression in Breast Cancer Cell Lines with AlphaLISA

Too many candidates, too little time. The lack of robust, rapid, high-throughput assays to identify and qualify potential therapeutic targets in areas such as cancer research continues to cost valuable time. What if you could increase assay throughput without compromising sensitivity, obtain more da ...

PDF 4 MB
Measuring PD-L1 and PD-1 Expression in Human Cells with LANCE Ultra TR-FRET

Immuno-oncology is an exciting area within cancer research and among the most promising approaches to activating therapeutic antitumor immunity is through the blockade of immune checkpoints. The programmed cell death-1 (PD-1) immune checkpoint pathway is a negative regulator of T cell immune functio ...

PDF 4 MB

Data Sheet